Advanced Lung Non-Squamous Non-Small Cell Carcinoma
4 clinical trials · Condition
◉ Watch Advanced Lung Non-Squamous Non-Small Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer (NCT05017025) | M.D. Anderson Cancer Center | 2022-02-17 |
| Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer (NCT04181060) | National Cancer Institute (NCI) | 2020-12-28 |
| Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial) (NCT04173507) | SWOG Cancer Research Network | 2020-02-14 |
| Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer (NCT02520778) | National Cancer Institute (NCI) | 2016-08-30 |
Track Advanced Lung Non-Squamous Non-Small Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.